journal article·2026-06-09Open access

Circulating Amino Acid Network Remodeling Reveals Systemic Metabolic Reprogramming Predictive of Colorectal Cancer Recurrence and Metastasis

Ji‐Yeon Lee, Jumi Kim, Taehan Yoon, So Hyun Kwon, Su Chan Park, Dohyun Chun, Dohyeong Kim, Eun Jung Park, Hyunwoo Kim, Ji Min Lee

Abstract

ABSTRACT Characterizing the dynamics of systemic metabolic pathways during cancer progression could enable the development of prognostic tools and therapeutic strategies. However, achieving this goal requires analytical platforms optimized for liquid biospecimens together with interpretive frameworks capable of identifying robust serum‐based biomarkers. Here, we establish a network‐based metabolic profiling framework using 1 9 F NMR–based serum amino acid analysis to characterize systemic metabolic remodeling during colorectal cancer (CRC) progression. Using an analytical protocol optimized for clinical serum samples, we quantified circulating amino acids from 152 CRC patients and implemented a ratio‐based normalization strategy to mitigate cohort variability in concentration‐based approaches. We systematically evaluated both individual amino acid changes and correlation structures across tumor stages. Advanced‐stage CRC exhibited a distinct metabolic shift characterized by decreased valine and increased glycine levels. Correlation network analysis further revealed stage‐dependent remodeling of circulating amino acid interactions, leading to the emergence of a glycine‐centered metabolic architecture. Importantly, machine‐learning models integrating individual amino acid levels with network‐derived features significantly improved the prediction of recurrence or metastasis compared with models using either feature type alone and outperformed conventional biomarker carcinoembryonic antigen (AUROC = 0.806). These findings highlight the remodeling of circulating amino acid network as a promising strategy for prognostic stratification and postoperative monitoring in CRC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Metabolomics and Mass Spectrometry Studies · Cancer, Hypoxia, and Metabolism · Microbial Metabolic Engineering and Bioproduction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Graduate School of Medical Science and Engineering Korea Advanced Institute of Science and Technology (KAIST) Daejeon Republic of Korea

Department of Chemistry Korea Advanced Institute of Science and Technology (KAIST) Daejeon Republic of Korea

Division of Colon and Rectal Surgery Department of Surgery Gangnam Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea

Division of Colon and Rectal Surgery Department of Surgery Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

Funding

National Research Foundation of Korea · Asan Institute for Life Sciences, Asan Medical Center

References (65)

Show source-provided references
1. 10.1126/science.aaw547310.1126/science.aaw5473 ↗
2. 10.1016/j.cmet.2015.12.00610.1016/j.cmet.2015.12.006 ↗
3. 10.1038/s42255‐023‐00963‐z10.1038/s42255‐023‐00963‐z ↗
4. 10.1126/science.116080910.1126/science.1160809 ↗
5. 10.1158/1078‐0432.CCR‐13‐193910.1158/1078‐0432.CCR‐13‐1939 ↗
6. Global Metabolic Reprogramming of Colorectal Cancer Occurs at Adenoma Stage and Is Induced by MYC
7. 10.1186/s13578‐023‐00977‐w10.1186/s13578‐023‐00977‐w ↗
8. 10.1038/s41698‐024‐00732‐510.1038/s41698‐024‐00732‐5 ↗
9. 10.1002/1878‐0261.1379110.1002/1878‐0261.13791 ↗
10. 10.1186/s12943‐024‐02119‐310.1186/s12943‐024‐02119‐3 ↗
11. 10.1016/j.cmet.2019.11.01210.1016/j.cmet.2019.11.012 ↗
12. 10.1016/j.tem.2021.03.00310.1016/j.tem.2021.03.003 ↗
13. 10.1038/s42255‐020‐00317‐z10.1038/s42255‐020‐00317‐z ↗
14. 10.1126/scisignal.abj422010.1126/scisignal.abj4220 ↗
15. 10.1016/j.ceb.2017.05.00610.1016/j.ceb.2017.05.006 ↗
16. Identification of Potential Metabolic Biomarkers of Rectal Cancer and of the Effect of Neoadjuvant Radiochemotherapy10.1371/journal.pone.0250453 ↗
17. 10.1021/pr900416210.1021/pr9004162 ↗
18. 10.1038/bjc.2016.24310.1038/bjc.2016.243 ↗
19. 10.1021/pr400337b10.1021/pr400337b ↗
20. 10.1186/gm34110.1186/gm341 ↗
21. 10.1186/s12916‐023‐02739‐410.1186/s12916‐023‐02739‐4 ↗
22. 10.1038/s41467‐022‐35511‐y10.1038/s41467‐022‐35511‐y ↗
23. 10.1186/s12967‐023‐04604‐710.1186/s12967‐023‐04604‐7 ↗
24. 10.2147/OTT.S27310710.2147/OTT.S273107 ↗
25. 10.1021/acs.analchem.6b0088510.1021/acs.analchem.6b00885 ↗
26. 10.1158/0008‐5472.CAN‐11‐154310.1158/0008‐5472.CAN‐11‐1543 ↗
27. Metabolomics Analysis in Serum From Patients With Colorectal Polyp and Colorectal Cancer by (1)H‐NMR Spectrometry
28. A Metabolic Study on Colon Cancer Using (1)h Nuclear Magnetic Resonance Spectroscopy10.1155/2014/348712 ↗
30. 10.6004/jnccn.2024.002910.6004/jnccn.2024.0029 ↗
31. The Eighth Edition AJCC Cancer Staging Manual: Continuing to Build a Bridge From a Population‐based to a More "Personalized" Approach to Cancer Staging
32. 10.18553/jmcp.2023.29.6.65910.18553/jmcp.2023.29.6.659 ↗
33. 10.3393/ac.2023.00458.006510.3393/ac.2023.00458.0065 ↗
34. 10.1007/s00726‐016‐2215‐210.1007/s00726‐016‐2215‐2 ↗
35. 10.3393/ac.2022.00367.005210.3393/ac.2022.00367.0052 ↗
36. 10.1021/acs.analchem.3c0448510.1021/acs.analchem.3c04485 ↗
37. 10.1016/j.str.2021.09.00910.1016/j.str.2021.09.009 ↗
38. 10.1038/s41598‐023‐49247‐210.1038/s41598‐023‐49247‐2 ↗
39. 10.1038/s41591‐022‐01980‐310.1038/s41591‐022‐01980‐3 ↗
40. Alterations in Serum Amino‐acid Profile in the Progression of Colorectal Cancer: Associations With Systemic Inflammation, Tumour Stage and Patient Survival10.1038/s41416-018-0357-6 ↗
41. Tissue Amino Acid Profiles Are Characteristic of Tumor Type, Malignant Phenotype, and Tumor Progression in Pancreatic Tumors10.1038/s41598-019-46404-4 ↗
42. 10.3389/fnut.2024.140071910.3389/fnut.2024.1400719 ↗
43. 10.1016/j.ccell.2019.12.01110.1016/j.ccell.2019.12.011 ↗
44. 10.1038/s12276‐024‐01263‐610.1038/s12276‐024‐01263‐6 ↗
45. 10.1146/annurev‐physiol‐020518‐11445510.1146/annurev‐physiol‐020518‐114455 ↗
46. 10.1038/s41467‐019‐13668‐310.1038/s41467‐019‐13668‐3 ↗
47. 10.1038/nrc355710.1038/nrc3557 ↗
48. 10.1016/j.cmet.2016.08.00910.1016/j.cmet.2016.08.009 ↗
49. 10.1126/science.117328810.1126/science.1173288 ↗
50. 10.1038/s12276‐020‐0375‐310.1038/s12276‐020‐0375‐3 ↗
51. 10.1038/s41568‐024‐00786‐410.1038/s41568‐024‐00786‐4 ↗
52. 10.1016/j.trecan.2023.02.00510.1016/j.trecan.2023.02.005 ↗
53. 10.1016/j.cmet.2018.12.02010.1016/j.cmet.2018.12.020 ↗
54. 10.1126/science.121859510.1126/science.1218595 ↗
55. 10.1038/s42255‐020‐00329‐910.1038/s42255‐020‐00329‐9 ↗
56. 10.1007/s13238‐017‐0451‐110.1007/s13238‐017‐0451‐1 ↗
57. 10.1186/s40164‐024‐00482‐x10.1186/s40164‐024‐00482‐x ↗
58. Cancer Cachexia: Understanding the Molecular Basis10.1038/nrc3829 ↗
59. 10.1016/j.cmet.2018.10.01310.1016/j.cmet.2018.10.013 ↗
60. 10.1016/j.cmet.2023.12.00110.1016/j.cmet.2023.12.001 ↗
61. 10.1038/nature2205610.1038/nature22056 ↗
62. 10.1038/s41467‐020‐20223‐y10.1038/s41467‐020‐20223‐y ↗
63. 10.1038/s41467‐022‐31248‐w10.1038/s41467‐022‐31248‐w ↗
64. 10.3389/fonc.2024.127720610.3389/fonc.2024.1277206 ↗
65. 10.1158/1055‐9965.EPI‐18‐093610.1158/1055‐9965.EPI‐18‐0936 ↗